Gregory J. Fleming, President & CEO of Rockefeller Capital Management, recently spoke with Dr. Jason Kelly, Co-Founder and CEO of Ginkgo Bioworks for a Uniquely Rockefeller Special Client Event entitled A New Paradigm for COVID-19 Testing.